Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeTax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Exozymes (EXOZ) EPS (Weighted Average and Diluted) (2023 - 2024)

Exozymes (EXOZ) has disclosed EPS (Weighted Average and Diluted) for 2 consecutive years, with -$0.25 as the latest value for Q4 2024.

  • Quarterly EPS (Weighted Average and Diluted) fell 38.89% to -$0.25 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$0.9 through Dec 2024, changed N/A year-over-year, with the annual reading at -$1.09 for FY2025, 22.47% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2024 was -$0.25 at Exozymes, up from -$0.27 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was -$0.08 in Q3 2023, with the low at -$0.27 in Q3 2024.